DACH1 a Key Protein for Tumor Suppression in ER+ Breast Cancer

EurekAlert -- Researchers from the Kimmel Cancer Center at Jefferson have identified a protein relationship that may be an ideal treatment target for ER+ breast cancer. The study was reported in the July 15 issue of Cancer Research.